MediciNova Shares Are Trading Higher After the Company Announced That It Received a Notice of Allowance From the U.S. Patent and Trademark Office for a Pending Patent Application, Which Covers MN-166 for Post-COVID Conditions.
MediciNova Shares Are Trading Higher After the Company Announced That It Received a Notice of Allowance From the U.S. Patent and Trademark Office for a Pending Patent Application, Which Covers MN-166 for Post-COVID Conditions.
美第奇新星生物技術股價上漲，公司宣佈獲得美國專利和商標局的一項通知准許，該通知覆蓋了關於MN-166用於新冠後狀況的待定專利申請。
MediciNova Shares Are Trading Higher After the Company Announced That It Received a Notice of Allowance From the U.S. Patent and Trademark Office for a Pending Patent Application, Which Covers MN-166 for Post-COVID Conditions.
美第奇新星生物技術股價上漲，公司宣佈獲得美國專利和商標局的一項通知准許，該通知覆蓋了關於MN-166用於新冠後狀況的待定專利申請。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間